The aim of the study is to determine which is the best treatment for people with cataract and primary angle closure (PAC).In PAC, apposition of the iris tissue to the drainage channels (Trabecular Meshwork-TM) of the eye results in damage and formation of adherences between these structures (Peripheral anterior synaechiae-PAS) causing a mechanical obstruction of the aqueous outflow via the TM. It is thought that cataract surgery combined with mechanical separation of the iris from the TM with the breakage of PAS(we call this separation 'goniosynechialysis') would make the pressure even lower as it would cause the drain to open to a greater extent than cataract surgery alone. This technique is not new, and the results have been very encouraging. Comparing this technique to cataract surgery alone however, has not been done and this is exactly what we would like to do in order to help us decide what is the best treatment.

In summary, the investigators propose that cataract surgery with goniosynechialysis would lower intraocular pressure to a greater extent than cataract surgery alone in patients with significant PAS.

Inclusion Criteria:

• Age ≥ 21 years.
• Diagnosis of PAC or PACG. PACG is defined as glaucomatous optic neuropathy in the opinion of a fellowship-trained glaucoma specialist, together with an IOP > 21mmHg on at least one occasion, and reproducible visual field defect (using the 24-2 test pattern on a Humphrey Field Analyser). PAC has all the above characteristics except for the visual field defect.
• More than 90 degrees of PAS (not necessarily contiguous).
• Lens opacity deemed sufficient to be causing decreased vision in the opinion of the supervising consultant (KSL).
• Ability to give informed consent.

Exclusion Criteria:

• Previous intraocular surgery or keratorefractive surgery.
• Previous eye trauma resulting in documented damage to the drainage angle (such as angle recession).
• History of uveitis.
• For patients on warfarin, INR >3.0 on day of surgery.
• Anterior segment neovascularisation.
• Chronic use of topical or systemic steroids.